Intuitive Surgical, Inc. $ISRG Holdings Raised by Valicenti Advisory Services Inc.

Valicenti Advisory Services Inc. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.5% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 29,962 shares of the medical equipment provider’s stock after acquiring an additional 2,335 shares during the period. Intuitive Surgical comprises about 2.9% of Valicenti Advisory Services Inc.’s holdings, making the stock its 10th biggest position. Valicenti Advisory Services Inc.’s holdings in Intuitive Surgical were worth $13,400,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Aaron Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after buying an additional 19 shares during the last quarter. Evergreen Capital Management LLC grew its holdings in shares of Intuitive Surgical by 0.5% during the first quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after buying an additional 20 shares during the last quarter. Rise Advisors LLC increased its position in shares of Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after acquiring an additional 20 shares during the period. Pinnacle Bancorp Inc. raised its stake in Intuitive Surgical by 4.1% in the 2nd quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after acquiring an additional 21 shares during the last quarter. Finally, Vertex Planning Partners LLC raised its stake in Intuitive Surgical by 2.3% in the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after acquiring an additional 21 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 104 shares of the business’s stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. The trade was a 81.80% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 114,007 shares of company stock valued at $63,533,844. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ISRG. BTIG Research boosted their price target on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn lifted their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Daiwa Capital Markets raised their target price on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Finally, Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $611.08.

Intuitive Surgical Stock Up 0.1%

ISRG stock opened at $577.81 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a 50-day simple moving average of $555.54 and a 200-day simple moving average of $507.11. The stock has a market capitalization of $207.13 billion, a P/E ratio of 76.43, a P/E/G ratio of 5.28 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the previous year, the firm posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.